top of page
Latest Articles and Analysis
Search


The Cure Hepatitis C Act of 2026 Bets on a National Drug Contract. The Design Could Narrow Access.
Congress has introduced the most ambitious federal hepatitis C elimination bill in a generation — $9.8 billion, no cost-sharing, and a delivery investment long overdue. The procurement model at its center could undermine the access it promises.
-
5 days ago8 min read


A New Era in the 340B Conversation: What Senator Cassidy's New Reform Bill Means for Patients
A new Senate bill would require 340B hospitals to document where their savings go and, for the first time, mandate direct discounts for low-income patients at the pharmacy counter. Here's what the proposal contains and why the stakes are high for the communities 340B was built to serve.

Kalvin Pugh
Jun 295 min read


340B - Are Patients at the Table or on the Menu? Reflections on the HELP Committee Hearing on 340B
Senate HELP Committee hearing reveals how 340B drug program expansion reflects hospital business strategy rather than patient benefit.

Kalvin Pugh
Nov 2, 20254 min read


Healthcare in the Lame Duck
Healthcare policy opportunities and threats during lame duck congressional session.
-
Dec 8, 202410 min read


Special Interests Favor S.4395, but Patients Oppose It...Here's Why
S.4395 would divert Ryan White resources from PLWHA to PrEP, threatening the safety net for vulnerable populations.

Jen Laws
Sep 25, 20228 min read


Congress Eyes Equipping Providers to Combat the Opioid Crisis; The MAT Act
MAT Act removes X-waiver requirements, expanding buprenorphine access especially in rural communities.

Jen Laws
Feb 6, 20222 min read
What a Narrowly Divided Senate Means for Health Policy
Narrowly divided Senate limits Biden's health policy agenda, making regulatory actions the primary reform path.

Jen Laws
Jan 17, 20213 min read
We Need Your Support Today!
bottom of page